Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J DeGraff

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
The American Journal of Pathology|April 25, 2015
Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder CancerOpal L Reddy, Justin M Cates, Lan L Gellert, et al.
Cell Reports|August 22, 2019
Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic ReprogrammingRaquel Buj, Chi-Wei Chen, Erika S Dahl, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Ensuring Successful Biomarker Studies in Bladder Preservation Clinical Trials for Non-muscle Invasive Bladder CancerDavid J McConkey, Brian C Baumann, Stephanie Cooper Greenberg, et al.
Nature Communications|April 17, 2021
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancerSia Viborg Lindskrog, Frederik Prip, Philippe Lamy, et al.
Nature Communications|December 23, 2022
Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiationJoshua I Warrick, Wenhuo Hu, Hironobu Yamashita, et al.
Nature Communications|November 3, 2022
FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiationJoshua I Warrick, Wenhuo Hu, Hironobu Yamashita, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
The American Journal of Pathology|April 25, 2015
Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder CancerOpal L Reddy, Justin M Cates, Lan L Gellert, et al.
Cell Reports|August 22, 2019
Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic ReprogrammingRaquel Buj, Chi-Wei Chen, Erika S Dahl, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Ensuring Successful Biomarker Studies in Bladder Preservation Clinical Trials for Non-muscle Invasive Bladder CancerDavid J McConkey, Brian C Baumann, Stephanie Cooper Greenberg, et al.
Nature Communications|April 17, 2021
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancerSia Viborg Lindskrog, Frederik Prip, Philippe Lamy, et al.
Nature Communications|December 23, 2022
Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiationJoshua I Warrick, Wenhuo Hu, Hironobu Yamashita, et al.
Nature Communications|November 3, 2022
FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiationJoshua I Warrick, Wenhuo Hu, Hironobu Yamashita, et al.
Pageof 7